Literature DB >> 11776271

The many varieties of catatonia.

M Fink1, M A Taylor.   

Abstract

About 10% of patients with severe acute psychiatric illness exhibit a cluster of motor signs (mutism, negativism, rigidity, posturing, stereotypy, staring, etc.) that are identified as the syndrome of catatonia. Catatonia responds to sedative anticonvulsant treatment (barbiturates, benzodiazepines) and to electroconvulsive therapy. These treatments raise seizure thresholds. The commonality in response indicates that catatonia, malignant catatonia, neuroleptic malignant syndrome, toxic serotonin syndrome, delirious mania, catatonic excitement, benign stupor, and oneirophrenia are best evaluated as diverse manifestations of one syndrome for clinical and neuroscience research purposes.

Entities:  

Mesh:

Year:  2001        PMID: 11776271     DOI: 10.1007/pl00014200

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  34 in total

1.  Quetiapine treatment for delirious mania in a military soldier.

Authors:  Woo Young Jung; Byung Dae Lee
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  Intoxications associated with agitation, tachycardia, hypertension, and Fever: differential diagnosis, evaluation, and management.

Authors:  Christopher J Keary; Shamim H Nejad; J J Rasimas; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2013-05-16

3.  Going Back to Kahlbaum's Psychomotor (and GABAergic) Origins: Is Catatonia More Than Just a Motor and Dopaminergic Syndrome?

Authors:  Dusan Hirjak; Katharina M Kubera; R Christian Wolf; Georg Northoff
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

Review 4.  Prevalence of Catatonia and Its Moderators in Clinical Samples: Results from a Meta-analysis and Meta-regression Analysis.

Authors:  Marco Solmi; G Giorgio Pigato; Beatrice Roiter; Argentina Guaglianone; Luca Martini; Michele Fornaro; Francesco Monaco; Andrè F Carvalho; Brendon Stubbs; Nicola Veronese; Christoph U Correll
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

Review 5.  Neuroleptic malignant syndrome or catatonia? Trying to solve the catatonic dilemma.

Authors:  Fabian U Lang; Silke Lang; Thomas Becker; Markus Jäger
Journal:  Psychopharmacology (Berl)       Date:  2014-11-20       Impact factor: 4.530

6.  Electroconvulsive therapy for treating schizophrenia: a chart review of patients from two catchment areas.

Authors:  Diana Kristensen; Jeanett Bauer; Ida Hageman; Martin Balslev Jørgensen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-12-05       Impact factor: 5.270

7.  Case reports of neuroleptic malignant syndrome in context of quetiapine use.

Authors:  Mark B Detweiler; Kelly Sullivan; Taral R Sharma; Kye Y Kim; Jonna G Detweiler
Journal:  Psychiatr Q       Date:  2013-12

Review 8.  The beginnings of modern psychiatric treatment in Europe. Lessons from an early account of convulsive therapy.

Authors:  Brigitta Baran; István Bitter; Gabor S Ungvari; Zoltán Nagy; Gábor Gazdag
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-05-26       Impact factor: 5.270

Review 9.  Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature.

Authors:  Max Fink; Edward Shorter; Michael A Taylor
Journal:  Schizophr Bull       Date:  2009-07-08       Impact factor: 9.306

10.  Catatonia in adolescence: a case report.

Authors:  Aditi Mehta; Erin Carlton; Kathleen Franco
Journal:  Psychiatry (Edgmont)       Date:  2008-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.